MedPath

Generlac

GENERLAC SOLUTION10 g/15 mL(Lactulose Solution, USP) For Oral or Rectal Administration Rx only

Approved
Approval ID

2a2eee86-273e-4718-8f78-34f15e193040

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 8, 2019

Manufacturers
FDA

Morton Grove Pharmaceuticals, Inc.

DUNS: 801897505

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lactulose

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60432-038
Application NumberANDA074603
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lactulose
Product Specifications
Route of AdministrationORAL, RECTAL
Effective DateJanuary 8, 2019
FDA Product Classification

INGREDIENTS (1)

LACTULOSEActive
Quantity: 10 g in 15 mL
Code: 9U7D5QH5AE
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Generlac - FDA Drug Approval Details